A multimarker study of degenerative aortic valve disease: Stenoinsufficiency shows more indices of bad prognosis

Annamaria Vianello, Stefano Perlini, Stefania Cappelli, Giuseppina Palladini, Maria Carmela Epistolato, Daniele Della Latta, Alfredo Cerillo, Sergio Berti, Dante Chiappino, Piero Tanganelli, Mattia Glauber, Annamaria Mazzone

Research output: Contribution to journalArticle

Abstract

Objectives: It was the aim of this study to assess the pathophysiological, prognostic role of aortic regurgitation (AR) in the 'mixed pictures' of degenerative aortic valve stenoinsufficiency (ASI) by a multimarker clinical approach. Methods: We enrolled 112 consecutive surgical patients: 19 with pure valve stenosis (PAS), 39 with mild regurgitation, 29 with severe regurgitation, and 25 controls with annulo-ectatic AR. All underwent complete echocardiography, carotid ultrasound and aortic/coronary multislice computed tomography calcium score evaluation. We determined tissue semiquantitative osteopontin, metalloproteinases (MMPs), tissue inhibitors of MMPs (TIMPs) and circulating brain natriuretic peptide. We evaluated major adverse cardiac events and cardiovascular early, long-term mortality after bioprosthetic valve implantation. Results: Tissue calcification, carotid and coronary atherosclerotic disease were prevalent in PAS versus ASI and AR patients. The multislice computed tomography calcium score (Agatston) was comparable between PAS and ASI (PAS 3,507.3 + 2,442.6; mild AR 4,270.7 + 2,213.5; severe AR 3,568.5 + 1,823.4), but much lower in AR (1,247.8 + 2,708.6). In ASI, a plasma/tissue 'profibrotic' MMP/TIMP balance prevailed, with circulating and echocardiographic indices of myocardial dysfunction. Percentages of major adverse cardiac events and early, long-term mortality were higher in ASI. Conclusions: In ASI, different, still unknown, genetic and dysplastic factors could work synergically with cardiovascular risk factors, determining a much more adverse myocardial and valve remodeling, resulting in worse clinical outcome.

Original languageEnglish
Pages (from-to)126-137
Number of pages12
JournalCardiology
Volume124
Issue number2
DOIs
Publication statusPublished - Mar 2013

Fingerprint

Aortic Diseases
Aortic Valve Insufficiency
Aortic Valve
Aortic Valve Stenosis
Matrix Metalloproteinase Inhibitors
Multidetector Computed Tomography
Matrix Metalloproteinases
Pathologic Constriction
Calcium
Osteopontin
Carotid Artery Diseases
Mortality
Brain Natriuretic Peptide
Metalloproteases
Coronary Disease
Echocardiography

Keywords

  • Atherosclerosis
  • Clinical outcome
  • Degenerative aortic valve disease
  • Stenoinsufficiency

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pharmacology (medical)

Cite this

Vianello, A., Perlini, S., Cappelli, S., Palladini, G., Epistolato, M. C., Della Latta, D., ... Mazzone, A. (2013). A multimarker study of degenerative aortic valve disease: Stenoinsufficiency shows more indices of bad prognosis. Cardiology, 124(2), 126-137. https://doi.org/10.1159/000346396

A multimarker study of degenerative aortic valve disease : Stenoinsufficiency shows more indices of bad prognosis. / Vianello, Annamaria; Perlini, Stefano; Cappelli, Stefania; Palladini, Giuseppina; Epistolato, Maria Carmela; Della Latta, Daniele; Cerillo, Alfredo; Berti, Sergio; Chiappino, Dante; Tanganelli, Piero; Glauber, Mattia; Mazzone, Annamaria.

In: Cardiology, Vol. 124, No. 2, 03.2013, p. 126-137.

Research output: Contribution to journalArticle

Vianello, A, Perlini, S, Cappelli, S, Palladini, G, Epistolato, MC, Della Latta, D, Cerillo, A, Berti, S, Chiappino, D, Tanganelli, P, Glauber, M & Mazzone, A 2013, 'A multimarker study of degenerative aortic valve disease: Stenoinsufficiency shows more indices of bad prognosis', Cardiology, vol. 124, no. 2, pp. 126-137. https://doi.org/10.1159/000346396
Vianello, Annamaria ; Perlini, Stefano ; Cappelli, Stefania ; Palladini, Giuseppina ; Epistolato, Maria Carmela ; Della Latta, Daniele ; Cerillo, Alfredo ; Berti, Sergio ; Chiappino, Dante ; Tanganelli, Piero ; Glauber, Mattia ; Mazzone, Annamaria. / A multimarker study of degenerative aortic valve disease : Stenoinsufficiency shows more indices of bad prognosis. In: Cardiology. 2013 ; Vol. 124, No. 2. pp. 126-137.
@article{573c433df5cf4a4ca3b3381a9249371c,
title = "A multimarker study of degenerative aortic valve disease: Stenoinsufficiency shows more indices of bad prognosis",
abstract = "Objectives: It was the aim of this study to assess the pathophysiological, prognostic role of aortic regurgitation (AR) in the 'mixed pictures' of degenerative aortic valve stenoinsufficiency (ASI) by a multimarker clinical approach. Methods: We enrolled 112 consecutive surgical patients: 19 with pure valve stenosis (PAS), 39 with mild regurgitation, 29 with severe regurgitation, and 25 controls with annulo-ectatic AR. All underwent complete echocardiography, carotid ultrasound and aortic/coronary multislice computed tomography calcium score evaluation. We determined tissue semiquantitative osteopontin, metalloproteinases (MMPs), tissue inhibitors of MMPs (TIMPs) and circulating brain natriuretic peptide. We evaluated major adverse cardiac events and cardiovascular early, long-term mortality after bioprosthetic valve implantation. Results: Tissue calcification, carotid and coronary atherosclerotic disease were prevalent in PAS versus ASI and AR patients. The multislice computed tomography calcium score (Agatston) was comparable between PAS and ASI (PAS 3,507.3 + 2,442.6; mild AR 4,270.7 + 2,213.5; severe AR 3,568.5 + 1,823.4), but much lower in AR (1,247.8 + 2,708.6). In ASI, a plasma/tissue 'profibrotic' MMP/TIMP balance prevailed, with circulating and echocardiographic indices of myocardial dysfunction. Percentages of major adverse cardiac events and early, long-term mortality were higher in ASI. Conclusions: In ASI, different, still unknown, genetic and dysplastic factors could work synergically with cardiovascular risk factors, determining a much more adverse myocardial and valve remodeling, resulting in worse clinical outcome.",
keywords = "Atherosclerosis, Clinical outcome, Degenerative aortic valve disease, Stenoinsufficiency",
author = "Annamaria Vianello and Stefano Perlini and Stefania Cappelli and Giuseppina Palladini and Epistolato, {Maria Carmela} and {Della Latta}, Daniele and Alfredo Cerillo and Sergio Berti and Dante Chiappino and Piero Tanganelli and Mattia Glauber and Annamaria Mazzone",
year = "2013",
month = "3",
doi = "10.1159/000346396",
language = "English",
volume = "124",
pages = "126--137",
journal = "Cardiology",
issn = "0008-6312",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - A multimarker study of degenerative aortic valve disease

T2 - Stenoinsufficiency shows more indices of bad prognosis

AU - Vianello, Annamaria

AU - Perlini, Stefano

AU - Cappelli, Stefania

AU - Palladini, Giuseppina

AU - Epistolato, Maria Carmela

AU - Della Latta, Daniele

AU - Cerillo, Alfredo

AU - Berti, Sergio

AU - Chiappino, Dante

AU - Tanganelli, Piero

AU - Glauber, Mattia

AU - Mazzone, Annamaria

PY - 2013/3

Y1 - 2013/3

N2 - Objectives: It was the aim of this study to assess the pathophysiological, prognostic role of aortic regurgitation (AR) in the 'mixed pictures' of degenerative aortic valve stenoinsufficiency (ASI) by a multimarker clinical approach. Methods: We enrolled 112 consecutive surgical patients: 19 with pure valve stenosis (PAS), 39 with mild regurgitation, 29 with severe regurgitation, and 25 controls with annulo-ectatic AR. All underwent complete echocardiography, carotid ultrasound and aortic/coronary multislice computed tomography calcium score evaluation. We determined tissue semiquantitative osteopontin, metalloproteinases (MMPs), tissue inhibitors of MMPs (TIMPs) and circulating brain natriuretic peptide. We evaluated major adverse cardiac events and cardiovascular early, long-term mortality after bioprosthetic valve implantation. Results: Tissue calcification, carotid and coronary atherosclerotic disease were prevalent in PAS versus ASI and AR patients. The multislice computed tomography calcium score (Agatston) was comparable between PAS and ASI (PAS 3,507.3 + 2,442.6; mild AR 4,270.7 + 2,213.5; severe AR 3,568.5 + 1,823.4), but much lower in AR (1,247.8 + 2,708.6). In ASI, a plasma/tissue 'profibrotic' MMP/TIMP balance prevailed, with circulating and echocardiographic indices of myocardial dysfunction. Percentages of major adverse cardiac events and early, long-term mortality were higher in ASI. Conclusions: In ASI, different, still unknown, genetic and dysplastic factors could work synergically with cardiovascular risk factors, determining a much more adverse myocardial and valve remodeling, resulting in worse clinical outcome.

AB - Objectives: It was the aim of this study to assess the pathophysiological, prognostic role of aortic regurgitation (AR) in the 'mixed pictures' of degenerative aortic valve stenoinsufficiency (ASI) by a multimarker clinical approach. Methods: We enrolled 112 consecutive surgical patients: 19 with pure valve stenosis (PAS), 39 with mild regurgitation, 29 with severe regurgitation, and 25 controls with annulo-ectatic AR. All underwent complete echocardiography, carotid ultrasound and aortic/coronary multislice computed tomography calcium score evaluation. We determined tissue semiquantitative osteopontin, metalloproteinases (MMPs), tissue inhibitors of MMPs (TIMPs) and circulating brain natriuretic peptide. We evaluated major adverse cardiac events and cardiovascular early, long-term mortality after bioprosthetic valve implantation. Results: Tissue calcification, carotid and coronary atherosclerotic disease were prevalent in PAS versus ASI and AR patients. The multislice computed tomography calcium score (Agatston) was comparable between PAS and ASI (PAS 3,507.3 + 2,442.6; mild AR 4,270.7 + 2,213.5; severe AR 3,568.5 + 1,823.4), but much lower in AR (1,247.8 + 2,708.6). In ASI, a plasma/tissue 'profibrotic' MMP/TIMP balance prevailed, with circulating and echocardiographic indices of myocardial dysfunction. Percentages of major adverse cardiac events and early, long-term mortality were higher in ASI. Conclusions: In ASI, different, still unknown, genetic and dysplastic factors could work synergically with cardiovascular risk factors, determining a much more adverse myocardial and valve remodeling, resulting in worse clinical outcome.

KW - Atherosclerosis

KW - Clinical outcome

KW - Degenerative aortic valve disease

KW - Stenoinsufficiency

UR - http://www.scopus.com/inward/record.url?scp=84874009183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874009183&partnerID=8YFLogxK

U2 - 10.1159/000346396

DO - 10.1159/000346396

M3 - Article

C2 - 23428667

AN - SCOPUS:84874009183

VL - 124

SP - 126

EP - 137

JO - Cardiology

JF - Cardiology

SN - 0008-6312

IS - 2

ER -